Hexagon Capital Partners LLC Cytosorbents Corp Transaction History
Hexagon Capital Partners LLC
- $524 Million
- Q1 2025
A detailed history of Hexagon Capital Partners LLC transactions in Cytosorbents Corp stock. As of the latest transaction made, Hexagon Capital Partners LLC holds 3,333 shares of CTSO stock, worth $2,799. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,333
Previous 3,333
-0.0%
Holding current value
$2,799
Previous $2,000
50.0%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding CTSO
# of Institutions
56Shares Held
17.2MCall Options Held
8.1KPut Options Held
6.9K-
Avenir Corp Washington, DC5.04MShares$4.24 Million0.55% of portfolio
-
Skylands Capital, LLC3MShares$2.52 Million0.48% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.95MShares$1.64 Million0.0% of portfolio
-
Neuberger Berman Group LLC New York, NY1.68MShares$1.41 Million0.0% of portfolio
-
Cm Management, LLC954KShares$801,4231.04% of portfolio
About Cytosorbents Corp
- Ticker CTSO
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 43,577,400
- Market Cap $36.6M
- Description
- Cytosorbents Corporation engages in the research, development, and commercialization of medical devices with its blood purification technology platform incorporating a proprietary adsorbent and porous polymer technology. Its flagship product is CytoSorb, an extracorporeal cytokine filter for adjunctive therapy in the treatment of sepsis, adjunct...